IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

H.I.G. Capital closes Ampac deal

10:13 AM MST | February 27, 2014 | Vincent Valk

Private equity firm H.I.G. Capital (Miami) says it has closed its $392-million acquisition of American Pacific (Ampac; Las Vegas) for $46.50/share, which was announced in January. Some 68.1% of American Pacific’s shares were tendered for $46.50 each in response to HIG’s tender offer, which expired yesterday. Ampac will now become a portfolio company of HIG capital. Ampac is the parent company of Ampac Fine Chemicals, a maker of pharma ingredients and intermediates for antiviral, oncology and central nervous system medications. Ampac shares, which...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa